Remarkably, HIF1α mRNA levels in circulating CLL vary significantly within patients, and HIF1α is upregulated, at the transcriptional level, in leukemic cells upon contact with stromal cells in a positive feedback loop that may foster CLL expansion and protection [103]. The gene discussed is HIF1A; the disease is B-cell chronic lymphocytic leukemia.